# Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy

> **NCT04507555** · NA · RECRUITING · sponsor: **PD Dr. med. Thorsten Mikoteit** · enrollment: 190 (estimated)

## Conditions studied

- Depression

## Interventions

- **PROCEDURE:** Pharmacist-guided pharmacogenetic (PGx) testing for antidepressant selection and dosing
- **PROCEDURE:** Standard care antidepressant selection and dosing

## Key facts

- **NCT ID:** NCT04507555
- **Lead sponsor:** PD Dr. med. Thorsten Mikoteit
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2025-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04507555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04507555, "Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04507555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*